Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference
Generation Bio (Nasdaq: GBIO), a biotechnology company focused on developing treatments for T cell-driven autoimmune diseases, has announced that its President and CEO, Geoff McDonough, M.D., will deliver a presentation at the upcoming Jefferies Global Healthcare Conference. The presentation is scheduled for Wednesday, June 4th, 2025, at 8:10 a.m. ET.
Interested parties can access a live webcast of the presentation through the investor section of Generation Bio's website at investors.generationbio.com. A replay of the presentation will remain available on the website for 30 days after the event.
Generation Bio (Nasdaq: GBIO), un'azienda biotecnologica specializzata nello sviluppo di trattamenti per malattie autoimmuni guidate dalle cellule T, ha annunciato che il suo Presidente e CEO, Geoff McDonough, M.D., terrà una presentazione durante la prossima Jefferies Global Healthcare Conference. La presentazione è prevista per mercoledì 4 giugno 2025 alle 8:10 ET.
Gli interessati possono seguire la diretta streaming della presentazione attraverso la sezione investitori del sito web di Generation Bio all'indirizzo investors.generationbio.com. Una registrazione della presentazione sarà disponibile sul sito per 30 giorni dopo l'evento.
Generation Bio (Nasdaq: GBIO), una compañía biotecnológica centrada en desarrollar tratamientos para enfermedades autoinmunes mediadas por células T, ha anunciado que su Presidente y CEO, Geoff McDonough, M.D., realizará una presentación en la próxima Jefferies Global Healthcare Conference. La presentación está programada para el miércoles 4 de junio de 2025 a las 8:10 a.m. ET.
Las personas interesadas pueden acceder a una transmisión en vivo de la presentación a través de la sección de inversores en el sitio web de Generation Bio en investors.generationbio.com. Una repetición de la presentación estará disponible en el sitio durante 30 días después del evento.
Generation Bio (나스닥: GBIO)는 T세포 주도 자가면역 질환 치료제 개발에 주력하는 바이오테크 기업으로, 사장 겸 CEO인 Geoff McDonough, M.D.가 다가오는 Jefferies Global Healthcare Conference에서 발표를 진행할 예정이라고 발표했습니다. 발표는 2025년 6월 4일 수요일 오전 8시 10분(동부시간)에 예정되어 있습니다.
관심 있는 분들은 Generation Bio 웹사이트의 투자자 섹션 investors.generationbio.com을 통해 발표 생중계에 접속할 수 있습니다. 발표 녹화 영상은 행사 후 30일간 웹사이트에서 다시보기로 제공됩니다.
Generation Bio (Nasdaq : GBIO), une entreprise de biotechnologie spécialisée dans le développement de traitements pour les maladies auto-immunes à médiation par les cellules T, a annoncé que son Président-directeur général, Geoff McDonough, M.D., donnera une présentation lors de la prochaine Jefferies Global Healthcare Conference. La présentation est prévue pour le mercredi 4 juin 2025 à 8h10 (heure de l’Est).
Les personnes intéressées peuvent accéder à la diffusion en direct de la présentation via la section investisseurs du site web de Generation Bio à l'adresse investors.generationbio.com. Une rediffusion de la présentation sera disponible sur le site pendant 30 jours après l'événement.
Generation Bio (Nasdaq: GBIO), ein Biotechnologieunternehmen, das sich auf die Entwicklung von Therapien für T-Zell-gesteuerte Autoimmunerkrankungen spezialisiert hat, hat bekannt gegeben, dass sein Präsident und CEO, Geoff McDonough, M.D., eine Präsentation auf der bevorstehenden Jefferies Global Healthcare Conference halten wird. Die Präsentation ist für Mittwoch, den 4. Juni 2025, um 8:10 Uhr ET geplant.
Interessierte können die Präsentation live über den Investor-Bereich auf der Website von Generation Bio unter investors.generationbio.com verfolgen. Eine Aufzeichnung der Präsentation wird für 30 Tage nach der Veranstaltung auf der Website verfügbar sein.
- None.
- None.
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the Jefferies Global Healthcare Conference on Wednesday, June 4th at 8:10 a.m. ET.
A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com. A replay will be available there for 30 days following the event.
About Generation Bio
Generation Bio is a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases. The company is developing redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells, which erroneously recognize and attack the body’s own tissues, causing autoimmune diseases. Generation Bio’s innovative approach leverages cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) to T cells. This combination of selective delivery and an intracellular, genetically precise mechanism of target engagement could unlock a series of high-value, historically undruggable disease-driving genes in autoimmunity.
For more information, please visit www.generationbio.com.
Investors and Media Contact
Maren Killackey
Generation Bio
mkillackey@generationbio.com
857-371-4638
FAQ
When is Generation Bio (GBIO) presenting at the Jefferies Global Healthcare Conference 2025?
Who will represent Generation Bio (GBIO) at the Jefferies Healthcare Conference 2025?
How can I watch Generation Bio's (GBIO) presentation at the Jefferies Conference?
What is Generation Bio's (GBIO) main focus as a company?
